InvitroCue Pte Ltd
5 articles with InvitroCue Pte Ltd
Invitrocue Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ended March 31, 2019 and to announce the appointment of Dr Sharifuddin Abdul Wahab as Global Insurance Advisor.
Dr. Fang is a co-founder and the Executive Director of Invitrocue with more than 20 years’ experience in leading and building successful healthcare companies.
Steven Fang, executive director of Invitrocue with offices in Australia, China and Singapore, took time to talk to BioSpace about the company and the Asian market for biopharma.
The Reporting Period represents another successful period of advancements for Invitrocue.
ImageIQ And InvitroCue Forge Partnership To Advance Quantitative Image Analysis For Preclinical Researchers In Asia